Nemaura Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Revenue	-	0.08	0.5	-	-	-
Revenue Growth (YoY)	-	-84.71%	-	-	-	-
Cost of Revenue	1.48	1.55	0.34	-	-	-
Gross Profit	-1.48	-1.48	0.16	-	-	-
Selling, General & Admin	8.41	5.6	6.17	3.03	2.77	2.18
Research & Development	1.89	1.54	1.56	1.55	2.01	2.3
Operating Expenses	10.3	7.14	7.73	4.59	4.78	4.48
Operating Income	-11.78	-8.62	-7.57	-4.59	-4.78	-4.48
Interest Expense	-5.67	-6.41	-6.67	-2.01	-	-
Interest & Investment Income	-	-	-	-	0	0.02
Other Non Operating Income (Expenses)	4.46	1.86	-	-	-	-
EBT Excluding Unusual Items	-9.67	-13.16	-14.24	-6.59	-4.77	-4.45
Asset Writedown	-0.98	-0.98	-	-	-	-
Pretax Income	-10.65	-14.14	-14.24	-6.59	-4.77	-4.45
Income Tax Expense	-	-	-0.35	-0.34	-0.61	-
Net Income	-10.65	-14.14	-13.89	-6.26	-4.16	-4.45
Net Income to Common	-10.65	-14.14	-13.89	-6.26	-4.16	-4.45
Shares Outstanding (Basic)	28	25	23	22	21	18
Shares Outstanding (Diluted)	28	25	23	22	21	18
Shares Change (YoY)	18.51%	6.39%	4.94%	7.10%	15.01%	20.55%
EPS (Basic)	-0.37	-0.57	-0.59	-0.28	-0.20	-0.25
EPS (Diluted)	-0.38	-0.57	-0.59	-0.28	-0.20	-0.25
Free Cash Flow	-9.74	-8.83	-6.99	-6.09	-3.61	-3.62
Free Cash Flow Per Share	-0.34	-0.35	-0.30	-0.27	-0.17	-0.20
Gross Margin	-	-	31.67%	-	-	-
Operating Margin	-	-11182.17%	-1502.35%	-	-	-
Profit Margin	-	-18358.00%	-2755.83%	-	-	-
Free Cash Flow Margin	-	-11458.32%	-1386.32%	-	-	-
EBITDA	-11.29	-8.17	-7.34	-4.49	-4.72	-4.44
D&A For EBITDA	0.49	0.44	0.23	0.1	0.05	0.03
EBIT	-11.78	-8.62	-7.57	-4.59	-4.78	-4.48

Updated Feb 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.